Nezavist a novel molecule for treatment of alcohol use disorder

Ended Cooperative Agreement Awarded Last action

Award ID
U44AA024905
Recipient
Awarding agency
Obligated
$7,990,344

Award facts

Assistance listing
93.273 Alcohol Research Programs
Completion date
Originally
Funding
  • $7,865,943.00 Federal
  • $124,401.00 Non-federal
Place of performance
Colorado, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $124,401 $0
Amendment Nezavist a novel molecule for treatment of alcohol use disorder - description (provided by applicant): alcohol use disorder affects 7.9% of the U.S.… $124,401 $124,401
Amendment $212,652 $0
Amendment $1,500,000 $0
Amendment $918,712 $0
Amendment -$35,771 $0
Amendment $35,771 $0
Amendment $0 $0
Amendment $1,500,000 $0
Amendment $1,500,000 $0
Amendment $0 $0
Amendment $985,777 $0
Original award $1,000,000 $0
Show all 20

Quick answers

Who received award U44AA024905?

U44AA024905 was awarded to Lohocla Research Corp by National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health) on September 25, 2015.

How much is award U44AA024905 worth?

$7,990,344 has been obligated on U44AA024905: $7,865,943 in federal funding and $124,401 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award